TIMP-1 regulates cell proliferation by interacting with the ninth zinc finger domain of PLZF

Journal of Cellular Biochemistry

Volumn 101, Issue 1, 2007, Pages 57-67

  Seung, Bae Rho ^a   Bo, Mee Chung ^a   Lee, Je Ho ^a,b  

^a Sungkyunkwan University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Apoptosis; Caspase 3; Matrix metalloproteinases; PLZF; Small interfering RNA; Transcriptional anti activator

Indexed keywords

COMPLEMENTARY DNA; PROMYELOCYTIC LEUKEMIA PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; ZINC FINGER PROTEIN;

ARTICLE; BINDING ASSAY; CANCER THERAPY; CELL PROLIFERATION; CONTROLLED STUDY; DNA LIBRARY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION; TWO HYBRID SYSTEM; UTERINE CERVIX CARCINOMA; ZINC FINGER MOTIF;

APOPTOSIS; CASPASE 3; CELL PROLIFERATION; DNA, COMPLEMENTARY; DRUG THERAPY, COMBINATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE LIBRARY; GENES, REPORTER; HELA CELLS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LUCIFERASES; NEOPLASM PROTEINS; NEOPLASMS, EXPERIMENTAL; NUCLEAR PROTEINS; OVARY; PRECIPITIN TESTS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RNA, SMALL INTERFERING; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS; TWO-HYBRID SYSTEM TECHNIQUES; UTERINE CERVICAL NEOPLASMS; ZINC FINGERS;

MAMMALIA;

EID: 34247507252     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21127     Document Type: Article

References (42)

1. Ahonen M, Poukkula M, Baker AH, Kashiwagi M, Nagase H, Eriksson JE, Kahari VM. 2003. Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors. Oncogene 22: 2121-2134.
2. Alexander CM, Howard EW, Bissell MJ, Werb Z. 1996. Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene. J Cell Biol 135:1669-1677.
3. Amour A, Knight CG, Webster A, Slocombe PM, Stephens PE, Knauper V, Docherty AJ, Murphy G. 2000. The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3. FEBS Lett 473:275-279.
4. Baker AH, Zaltsman AB, George SJ, Newby AC. 1998. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. J Clin Invest 101:1478-1487.
5. Ball HJ, Melnick A, Shaknovich R, Kohanski RA, Licht JD. 1999. The promyelocyte leukemia zinc finger (PLZF) protein binds DNA in a high molecular weight complex associated with cdc2 kinase. Nucleic Acids Res 27:4106-4113.
6. Barasch J, Yang J, Qiao J, Tempst P, Erdjument-Bromage H, Leung W, Oliver JA. 1999. Tissue inhibitor of metalloproteinase-2 stimulates mesenchymal growth and regulates epithelial branching during morphogenesis of the rat metanephros. J Clin Invest 103:1299-1307.
7. Bardwell VJ, Treisman R. 1994. The POZ domain: A conserved protein-protein interaction motif. Genes Dev 8:1664-1677.
8. Barna M, Hawe N, Niswarider L, Pandolfi PP. 2000. Plzf regulates limb and axial skeletal patterning. Nat Genet 25:166-172.
9. Bond M, Murphy G, Bennett MR, Newby AC, Baker AH. 2002. Tissue inhibitor of metalloproteinase-3 induces a Fas-associated death domain-dependent type II apoptotic pathway. J Biol Chem 277:13787-13795.
10. David G, Alland L, Hong SH, Wong CW, DePinho RA, Dejean A. 1998. Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein. Oncogene 16:2549-2556.
11. Fernandez CA, Butterfield C, Jackson G, Moses MA. 2003. Structural and functional uncoupling of the enzymatic and angiogenic inhibitory activities of tissue inhibitor of metalloproteinase-2 (TIMP-2): Loop 6 is a novel angiogenesis inhibitor. J Biol Chem 278:40989-40995.
12. Grignani F, Matteis SD, Nervi C, Tomassoni NL, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara FF, Zamir I, Seiser C, Lazar MA, Minucci S, Pelicci PG. 1998. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature 391:815-818.
13. Guedez L, Stetler-Stevenson WG, Wolff L, Wang J, Fukushima P, Mansoor A, Stetler-Stevenson M. 1998a. In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J Clin Invest 102:2002-2010.
14. Guedez L, Courtemanch L, Stetler-Stevenson M. 1998b. Tissue inhibitor of metalloproteinase (TIMP)-1 induces differentiation and an antiapoptotic phenotype in germinal center B cells. Blood 92:1342-1349.
15. Guidez F, Ivins S, Zhu J, Soderstrom M, Waxman S, Zelent A. 1998c. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia. Blood 91:2634-2642.
16. Han SH, Jeon JH, Ju HR, Jung U, Kim KY, Yoo HS, Lee YH, Song KS, Hwang HM, Na Y-S, Yang Y, Lee KN, Choi I. 2003. VDUP1 upregulated by TGF-β1 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression. Oncogene 22:4035-4046.
17. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K. 1992. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett 298:29-32.
18. Hong SH, David G, Wong CW, Dejean A, Privalsky ML. 1997. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia. Proc Natl Acad Sci USA 94: 9028-9033.
19. Ito H, Fukada Y, Murata K, Kimura A. 1983. Transformation of intact yeast cells treated with alkali cations. J Bacteriol 153:163-168.
20. Jiang Y, Wang M, Celiker MY, Liu YE, Sang QX, Goldberg ID, Shi YE. 2001. Stimulation of mammary tumorigenesis by systemic tissue inhibitor of matrix metalloproteinase 4 gene delivery. Cancer Res 61:2365-2370.
21. Juliano RL, Haskill S. 1993. Singal transduction from the extracellular matrix. J Cell Biol 120:577-585.
22. Kang SI, Chang WJ, Cho SG, Kim IY. 2003. Modification of promyelocytic leukemia zinc finger protein (PLZF) by SUMO-1 conjugation regulates its transcriptional repressor activity. J Biol Chem 278:51479-51483.
23. Lambert E, Dasse E, Haye B, Petitfrere E. 2004. TIMPs as multifacial proteins. Crit Rev Oncol Hematol 49:187-198.
24. Lee SJ, Yoo HJ, Bae YS, Kim HJ, Lee ST. 2003. TIMP-1 inhibits apoptosis in breast carcinoma cells via a pathway involving pertussis toxin-sensitive G protein and c-Src. Biochem Biophys Res Commun 312:1196-1201.
25. Li H, Nishio K, Yamashita K, Hayakawa T, Hoshino T. 1995. Cell cycle-dependent localization of tissue inhibitor of metalloproteinases-1 immunoreactivity in cultured human gingival fibroblasts. Nagoya J Med Sci 58:133-142.
26. Li JY, English MA, Ball HJ, Yeyati PL, Waxman S, Licht JD. 1997. Sequence-specific DNA binding and transcriptional regulation by the promyelocytic leukemia zinc finger protein. J Biol Chem 272:22447-22455.
27. Li G, Fridman R, Kim HR. 1999. Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells. Cancer Res 59:6267-6275.
28. Liu XW, Bernardo MM, Fridman R, Kim HR. 2003. Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase/phosphatidylinositol 3-kinase and MAPK signaling pathway. J Biol Chem 278:40364-40372.
29. Liu XW, Taube ME, Jung KK, Dong Z, Lee YJ, Roshy S, Sloane BF, Fridman R, Kim HR. 2005. Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells from extrinsic cell death: A potential oncogenic activity of tissue inhibitor of metalloproteinase-1. Cancer Res 65:898-906.
30. Melnick A, Ahmad KF, Arai S, Polinger A, Ball H, Borden KL, Carlile GW, Prive GG, Licht JD. 2000. In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions. Mol Cell Biol 20:6550-6567.
31. Parrado A, Robledo M, MoyaQuiles MR, Marin LA, Chomienne C, Padua RA, AlvarezLopez MR. 2004. The promyelocytic leukemia zinc finger protein down-regulates apoptosis and expression of the proapoptotic BID protein in lymphocytes. Proc Natl Acad Sci USA 101:1898-1903.
32. Qi JH, Ebrahem Q, Moore N, Murphy G, Claesson-Welsh L, Bond M, Baker A, Anand-Apte B. 2003. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): Inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med 9:407-415.
33. Rho SB, Lee KH, Kim JW, Shiba K, Jo YJ, Kim S. 1996. Interaction between human tRNA synthetases involves repeated sequence elements. Proc Natl Acad Sci USA 93: 10128-10133.
34. Rho SB, Chun T, Lee SH, Park K, Lee JH. 2004. The interaction between E-tropomodulin and thymosin β-10 rescues tumor cells from thymosin β-10 mediated apoptosis by restoring actin architecture. FEBS Lett 557:57-63.
35. Ritter LM, Garfield SH, Thorgeirsson UP. 1999. Tissue inhibitor of metalloproteinases-1 (TIMP-1) binds to the cell surface and translocates to the nucleus of human MCF-7 breast carcinoma cells. Biochem Biophys Res Commun 257:494-499.
36. Sitterlin D, Tiollais P, Transy C. 1997. The RAR alpha-PLZF chimera associated with Acute Promyelocytic Leukemia has retained a sequence-specific DNA-binding domain. Oncogene 14:1067-1074.
37. Tummalapalli CM, Heath BJ, Tyagi SC. 2001. Tissue inhibitor of metalloproteinase-4 instigates apoptosis in transformed cardiac fibroblasts. J Cell Biochem 80:512-521.
38. Visse R, Nagase H. 2003. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and bichemiatry. Circ Res 92:827-839.
39. Whitelock JM, Murdoch AD, Iozzo RV, Underwood PA. 1996. The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. J Biol Chem 271:10079-10086.
40. Yeyati PL, Shaknovich R, Boterashvili S, Li J, Ball HJ, Waxman S, NasonBurchenal K, Dmitrovsky E, Zelent A, Licht JD. 1999. Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin A. Oncogene 18:25-934.
41. Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H, Yanase K, Namisaki T, Imazu H, Fukui H. 2002. Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse. Hepatology 36:850-860.
42. Zhao WQ, Li H, Yamashita K, Guo XK, Hoshino T, Yoshida S, Shinya T, Hayakawa T. 1998. Cell cycle-associated accumulation of tissue inhibitor of metalloproteinases-1 (TIMP-1) in the nuclei of human gingival fibroblasts. J Cell Sci 111:1147-1153.